Newspaper Publication of Q3 Results
Latest Announcements
AGM Notice Announcement
8 Sep 2017 | Read More
Board Meeting Notice July 27, 2017
14 Jul 2017 | Read More
Glenmark FPJ Page 10
14 Jul 2017 | Read More
Glenmark Navshakti Page 8
14 Jul 2017 | Read More
Glenmark Pharmaceuticals Receives Tentative ANDA Approval For Solifenacin Succinate Tablets, 5 mg and 10 mg
22 Jun 2017 | Read More
Glenmark's consolidated revenue increased by 6.52% to Rs. 24,571.83 Mn for Q4 FY 2016 -- 17
11 May 2017 | Read More
Q4 FY 2017 Results sheet & Statement of Assets and Liabilities
11 May 2017 | Read More
Q4 FY 2017 Management Discussions and Analysis
11 May 2017 | Read More
Q4 Earnings Concall Invitation May 12, 2017
8 May 2017 | Read More
The Free Press Journal
5 May 2017 | Read More
Navshakti
5 May 2017 | Read More
Intimation regarding NSE board meeting
3 May 2017 | Read More
Statement on Form 483 at the Ankleshwar API plant
20 Feb 2017 | Read More
Glenmark’s consolidated revenue increases by 42.55 % to Rs. 25,350.08 Mn for Q3 FY 2016 – 17
2 Feb 2017 | Read More
Glenmark’s Q3 FY 17 results
2 Feb 2017 | Read More
Glenmark’s MDA Q3 FY 17
2 Feb 2017 | Read More
J P Morgan Healthcare Conference – presentation
30 Jan 2017 | Read More
Intimation regarding board meeting
17 Jan 2017 | Read More
Statement of Investor Complaints for Q3 (F. Y. 2016-17)
11 Jan 2016 | Read More
Webcast of analyst and investor meet 2016
29 Dec 2016 | Read More
Strategic Blueprint for the Next Decade – Investor presentation
19 Dec 2016 | Read More
Strategic Blueprint for the Next Decade – Media presentation
19 Dec 2016 | Read More
Glenmark's Q2 FY17 Result Balance Sheet
2 Nov 2016 | Read More
Glenmark's MDA Q2 FY 2017
2 Nov 2016 | Read More
Glenmark’s consolidated revenue increases by 16.48% to Rs. 22241.09 Mn for Q2 FY 2016 – 17
2 Nov 2016 | Read More
Shareholding Pattern for Q2
10 Oct 2016 | Read More
Corporate Governance Report for Q2
10 Oct 2016 | Read More
Reconciliation of Share Capital Audit Report
10 Oct 2016 | Read More
Compliance Certificate under Regulation 7(3)
10 Oct 2016 | Read More
Certificate from Practicing Company Secretary under Regulation 40(9)
10 Oct 2016 | Read More
Statement of Investor Complaints for Q2
10 Oct 2016 | Read More
38th AGM Proceedings
12 Aug 2016 | Read More
38th AGM Notice – The Free Press Journal
21 Jul 2016 | Read More
38th AGM Notice – Navshakti
21 Jul 2016 | Read More
Glenmark e-voting notice
19 Jul 2016 | Read More
Glenmark notice proxy form
19 Jul 2016 | Read More
Annual report FY 2016
19 Jul 2016 | Read More
Intimation to the exchange
18 Jul 2016 | Read More
Statement of Investor Complaint
13 Jul 2016 | Read More
Reconciliation Share Capital
30 Jun 2016 | Read More
Q4 Shareholding Pattern
30 Jun 2016 | Read More
Corporate governance website
30 Jun 2016 | Read More
Approval of Subscription Agreement for FCCB's
31 May 2016 | Read More
Launch of FCCB's
31 May 2016 | Read More
Q4 - Statement of Investor Complaints
7 Apr 2016 | Read More
Q4 - Format of Holding of specified securities
31 Mar 2016 | Read More
Q4 - Reconciliation Share Capital
31 Mar 2016 | Read More
Q4 - Format of Holding of specified securities (2)
31 Mar 2016 | Read More
Authorised KMP for Disclosure of Materality of Events or Information
28 Jan 2016 | Read More
Cancellations of ESOP Options
28 Jan 2016 | Read More
Glenmark JPMorgan 2016
15 Jan 2016 | Read More

About Us
Leading, integrated, global, research-led organization. Words which define us and our vision to discover a healthier futureContact Us
For shareholder queries, please email to
complianceofficer@glenmarkpharma.com